E-ISSN 2146-3077
Case Report
Successful Treatment of Cutaneous Leishmaniasis with Amphotericin B; A Case of Unresponsive to Pentavalent Antimony Therapy
1 Harran Üniversitesi Tıp Fakültesi, Dermatoloji Anabilim Dalı, Şanlıurfa, Türkiye  
2 Özel OSM Hastanesi, Dermatoloji Anabilim Dalı, Şanlıurfa, Türkiye  
3 Celal Bayar Üniversitesi Tip Fakültesi, Parazitoloji Anabilim Dalı, Manisa, Türkiye  
Turkiye Parazitol Derg 2015; 39: 63-65
DOI: 10.5152/tpd.2015.3761
This article was viewed 1308 times, downloaded 1212 times

Key Words: Cutaneous leishmaniasis, liposomal amphoteric B treatment, pentavalent antimonials
Abstract

Cutaneous Leishmaniasis (CL) is a skin infection caused by various species of Leishmania parasites, which is transmitted by infected Phlebotomus sandfly bites. Pentavalent antimonials (meglumine antimoniate and sodium stibogluconate) are used for the treatment of adult CL patients as an effective and safe method. Liposomal amphotericin B is an alternative for the treatment of choice in cutaneous leishmaniasis cases which pentavalan antimony contraindicated or unresponsive to pentavalent antimony therapy. In this study, successful treatment with systemic liposomal amphotericin B of a cutaneous leishmaniasis case developing local side effects related both systemic and intralesional meglumine antimonate treatment was presented. 

Key Words
Authors
All
Reviewer's Corner
Survey
AVES | Copyright © 2018 Turkish Parasitology Association | Latest Update: 10.01.2018